Clinical Trial Update: AMG 386 Drug-Drug Interaction Study With Paclitaxel [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the drug-drug interaction of AMG 386 with paclitaxel in patients with advanced solid tumors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AMG-386 (trebananib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Amgen | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED